Group Leader
Garvan Institute of Medical Research, Australia
Dr Mandy Ballinger is Leader of the Genetic Cancer Risk Group at the Garvan Institute of Medical Research, Head of Cohorts for Omico and on the leadership team at the new Centre for Molecular Oncology at the University of New South Wales. Her clinical training includes a Masters in Genetic Counselling. She oversees a program of work focused on defining heritable cancer risk using large cohort studies. Her work in Li Fraumeni syndrome risk management has impacted clinical practice internationally and has recently led to successful application for an Australian Medicare item number for early cancer detection. Dr Ballinger continues to use research cohorts as vehicles for intervention to impact on clinical practice and improve outcomes for individuals and their families.
